Sunday, March 26, 2017
 
 
Company News: Page (1) of 1 - 03/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Tony Blair Opens New High Volume Breath Biopsy Lab for Owlstone Medical

(March 17, 2017)

New facilities will enable high quality and high throughput Biomarker Services, for identification of novel breath biomarkers in disease diagnostics and precision medicine applications

CAMBRIDGE, England--(BUSINESS WIRE)--Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today welcomed Tony Blair to its headquarters in Cambridge, UK where he officially opened the companys new high volume clinical laboratory.


During the visit, Mr Blair learned more about the companys Breath Biopsy® technology and its mission to save 100,000 lives and $1.5 billion in healthcare costs. He was also given a tour of Owlstone Medical headquarters including the new clinical lab and other research facilities.

The opening of a new clinical lab with increased capacity enables Owlstone Medical to offer high quality and high throughput Biomarker Services to academics, clinicians, pharmaceutical companies and CROs to identify novel breath biomarkers for disease diagnostics as well as precision medicine applications including therapeutic response, patient stratification and outcome prediction.


The clinical lab also provides VOC biomarker analysis of breath samples and other biospecimens from the on-going clinical trials in Owlstone Medicals own clinical pipeline: early detection of lung cancer (LuCID), colorectal cancer (InTERCEPT) and treatment stratification in asthma (STRATA).

Billy Boyle, co-founder and CEO at Owlstone Medical commented: ?Our new high volume clinical lab follows the successful commercial launch of our Biomarker Services earlier this year and the announcement of our first clinical and pharma customers. Having a state-of-the-art and globally unique capability allows us to increase capacity to handle large service projects as well as support our ongoing clinical trials.

Tony Blair said: ?I congratulate Owlstone Medical on the opening of its new clinical lab. It was a pleasure to meet the dedicated staff of this successful, dynamic company, united in their clear vision to save lives. The breath biopsy technology has huge potential to lead to great improvements in healthcare, and I wish the team every success in developing a company that will become a leader in next generation diagnostics.

To find out more about Owlstone Medical visit: www.owlstonemedical.com

https://www.owlstonemedical.com/about/news/2017/mar/17/tony-blair-opens-new-high-volume-breath-biopsy-lab


Contacts

Owlstone Medical
Sarah Jeffery
sarah.jeffery@zymecommunications.com


Page: 1


Related Keywords:
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines